HK1037958A1 - Skin and tissue care and/or treatment agent - Google Patents
Skin and tissue care and/or treatment agentInfo
- Publication number
- HK1037958A1 HK1037958A1 HK01107891A HK01107891A HK1037958A1 HK 1037958 A1 HK1037958 A1 HK 1037958A1 HK 01107891 A HK01107891 A HK 01107891A HK 01107891 A HK01107891 A HK 01107891A HK 1037958 A1 HK1037958 A1 HK 1037958A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- skin
- treatment agent
- tissue care
- metal salts
- antipsoriatic
- Prior art date
Links
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 abstract 2
- -1 alkali metal salts Chemical class 0.000 abstract 2
- 102000004310 Ion Channels Human genes 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000002682 anti-psoriatic effect Effects 0.000 abstract 1
- 230000003356 anti-rheumatic effect Effects 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 239000000824 cytostatic agent Substances 0.000 abstract 1
- 230000001085 cytostatic effect Effects 0.000 abstract 1
- 238000009792 diffusion process Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 210000003093 intracellular space Anatomy 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 230000004089 microcirculation Effects 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 150000002978 peroxides Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000011787 zinc oxide Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/22—Peroxides; Oxygen; Ozone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A composition (I) containing (a) at least one salt selected from alkali metal salts, alkaline earth metal salts and other minerals, additionally contains (b) at least one aminoacid and (c) zinc oxide and/or an inorganic peroxide. ACTIVITY : Dermatological; antipsoriatic; antirheumatic; cytostatic; gastrointestinal. MECHANISM OF ACTION : (I) promotes diffusion of ions through ion channels into the intracellular space to improve microcirculation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19831798A DE19831798A1 (en) | 1998-07-15 | 1998-07-15 | Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement |
PCT/DE1999/002202 WO2000003689A2 (en) | 1998-07-15 | 1999-07-15 | Skin and tissue care and/or treatment agent |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1037958A1 true HK1037958A1 (en) | 2002-03-01 |
Family
ID=7874155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK01107891A HK1037958A1 (en) | 1998-07-15 | 2001-11-09 | Skin and tissue care and/or treatment agent |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP1639991A3 (en) |
JP (1) | JP3917370B2 (en) |
KR (1) | KR100542606B1 (en) |
CN (1) | CN1201723C (en) |
AT (1) | ATE308968T1 (en) |
AU (1) | AU761947B2 (en) |
BR (1) | BR9912821A (en) |
CA (1) | CA2337772C (en) |
DE (3) | DE19831798A1 (en) |
DK (1) | DK1096918T3 (en) |
ES (1) | ES2252976T3 (en) |
HK (1) | HK1037958A1 (en) |
HU (1) | HUP0103236A2 (en) |
IL (1) | IL140889A0 (en) |
NO (1) | NO20010220L (en) |
PL (1) | PL345689A1 (en) |
WO (1) | WO2000003689A2 (en) |
ZA (1) | ZA200101244B (en) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7629384B2 (en) | 1997-09-17 | 2009-12-08 | Strategic Science & Technologies, Llc | Topical delivery of L-arginine to cause beneficial effects |
US7914814B2 (en) | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
DE20005402U1 (en) | 2000-03-22 | 2000-07-20 | Schilling Johann Georg | External treatment for skin redness and psoriasis |
JP4532706B2 (en) * | 2000-09-08 | 2010-08-25 | 花王株式会社 | Cosmetics |
DE10109798A1 (en) * | 2001-03-01 | 2002-09-12 | Aventis Pharma Gmbh | Food additives for treatment or prevention of symptoms of diabetes, osteoarthritis, osteoporosis, asthma, mental decline and age related eye disease |
DE10133202A1 (en) * | 2001-07-07 | 2003-01-16 | Beiersdorf Ag | Topical compositions containing osmolytes, useful e.g. for treating or preventing dry skin or inflammatory conditions of the skin, e.g. eczema, polymorphic light dermatosis or psoriasis |
DE10133203A1 (en) * | 2001-07-07 | 2003-01-16 | Beiersdorf Ag | Topical compositions containing catechins and/or their gallate esters, useful e.g. for treating or preventing dry skin or inflammatory conditions of the skin, e.g. eczema, polymorphic light dermatosis or psoriasis |
DE20209676U1 (en) | 2002-06-22 | 2002-09-26 | Stubna, Eduard, 80634 München | Tattoo removal preparations |
DE10243437A1 (en) * | 2002-09-18 | 2004-04-29 | Pm-International Ag | Cosmetic formulation |
US7480530B2 (en) | 2003-06-30 | 2009-01-20 | Johnson & Johnson Consumer Companies, Inc. | Device for treatment of barrier membranes |
US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
EP1732577B1 (en) * | 2004-02-23 | 2013-04-10 | Strategic Science & Technologies, LLC | Topical delivery of l-arginine to improve body and skin appearance |
EP1735001A2 (en) * | 2004-03-24 | 2006-12-27 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs |
JP2007532697A (en) | 2004-04-19 | 2007-11-15 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | The beneficial effects of increased local blood flow |
US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
AT501221A1 (en) * | 2005-01-14 | 2006-07-15 | Hermine Dr Engl | ACTIVE COMPOUND |
SG10201502232SA (en) * | 2006-03-22 | 2015-05-28 | Takasago Perfumery Co Ltd | Deodorant composition |
EP2155235B1 (en) | 2007-04-09 | 2016-04-06 | Wake Forest University Health Sciences | Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
AU2013203151B2 (en) * | 2007-04-09 | 2015-05-21 | Wake Forest University Health Sciences | Oxygen-generating compositions for enhancing cell and tissue survival in vivo |
FR2916351B1 (en) * | 2007-05-22 | 2012-12-07 | Galderma Res & Dev | PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST TWO COMPOUNDS SELECTED BY PYRROLIDONE-5-CARBOXYLIC ACID, CITRULLINE, ARGININE AND ASPARAGINE AND THEIR USE IN THE TREATMENT OF ATOPIC DERMATITIS |
JP5537046B2 (en) * | 2009-02-20 | 2014-07-02 | 花王株式会社 | Body rinse |
US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
US9072659B2 (en) | 2009-06-24 | 2015-07-07 | Strategic Science & Technologies, Llc | Topical composition containing naproxen |
AU2009348470B2 (en) | 2009-06-24 | 2015-04-02 | Strategic Science & Technologies, Llc | Topical composition containing ibuprofen |
ES2617760T3 (en) | 2009-11-13 | 2017-06-19 | Johnson & Johnson Consumer Inc. | Galvanic device for skin treatment |
EP2658551B1 (en) | 2010-12-29 | 2020-07-01 | Strategic Science & Technologies, LLC | Treatment of erectile dysfunction and other indications |
US9289495B2 (en) | 2010-12-29 | 2016-03-22 | Strategic Science & Technologies, Llc | Systems and methods for treatment of allergies and other indications |
CN102688483B (en) * | 2011-03-22 | 2015-02-18 | 王成德 | Composition for treating dermatosis, preparation containing composition and preparation method thereof |
RU2457778C1 (en) * | 2011-05-11 | 2012-08-10 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей" Министерства здравоохранения и социального развития Российской Федерации | Method of diagnosing disorder of microcirculation of small intestine in patients with diffuse peritonitis |
DE102011109868A1 (en) * | 2011-08-10 | 2013-02-14 | STERNA BIOLOGICALS GmbH & Co. KG. | Multiple emulsion |
WO2014041528A2 (en) * | 2012-09-14 | 2014-03-20 | Martin Roslain Margaret | A composition |
CN104936587A (en) | 2012-12-26 | 2015-09-23 | 株式会社Az | Wound healing accelerator |
CN104173232A (en) * | 2014-08-06 | 2014-12-03 | 金玲 | Method for preparing beautifying fluid capable of promoting skin resistance and repairing small-invasive skin |
CN104189000A (en) * | 2014-09-12 | 2014-12-10 | 朴荣范 | Traumatism liquid medicine and preparation method thereof |
WO2016128235A1 (en) * | 2015-02-11 | 2016-08-18 | Nestec S.A. | Vitamin a composition |
CN105901703B (en) * | 2016-04-19 | 2020-03-10 | 上海海洋大学 | Marine organism type enteral nutrition preparation for burn patients |
US11260005B2 (en) | 2016-12-21 | 2022-03-01 | Conopco, Inc. | Personal care compositions with glutathione precursor comprising 4-substituted resorcinols and amino acids |
CN110121331B (en) | 2016-12-21 | 2022-09-16 | 联合利华知识产权控股有限公司 | Personal care compositions containing poorly soluble compounds |
CA3047215A1 (en) | 2016-12-21 | 2018-06-28 | Unilever Plc | Personal care compositions with cystine |
CN110099672B (en) | 2016-12-21 | 2022-05-24 | 联合利华知识产权控股有限公司 | Topical skin lightening additives and compositions with amino acid and nicotinamide compounds |
CA3098981A1 (en) | 2018-05-23 | 2019-11-28 | Unilever Plc | Nanoemulsions and a method for making the same |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3861868A (en) * | 1971-03-30 | 1975-01-21 | Procter & Gamble | Dyeing human hair with oxidation dyes and arginine or a protamine protein |
DE2840498C2 (en) * | 1978-09-18 | 1980-04-10 | Walter Dr. 6700 Ludwigshafen Schweckendiek | Pharmaceutical preparations for the treatment of psoriasis |
US4283386A (en) * | 1978-10-10 | 1981-08-11 | Scott Eugene J Van | Method for hair care |
NZ223558A (en) * | 1987-02-18 | 1990-04-26 | Milor Scient Ltd | Acne treatment composition |
DE3905299C1 (en) * | 1989-02-21 | 1990-08-09 | Peter Prof. Dr.Med. 7980 Ravensburg De Klein | |
FR2651125B1 (en) * | 1989-08-23 | 1992-10-02 | Roussel Uclaf | PHARMACEUTICAL COMPOSITIONS OF THE "WATER PASTE" TYPE. |
WO1991011117A2 (en) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Dietary supplements comprising vitamins and minerals |
FR2674755B1 (en) * | 1991-04-05 | 1995-02-03 | Thorel Jean Noel | NEW IMMUNOSTIMULATORY DRUG COMPOSITIONS. |
US5681852A (en) * | 1993-11-12 | 1997-10-28 | The Procter & Gamble Company | Desquamation compositions |
FR2727014A1 (en) * | 1994-11-18 | 1996-05-24 | Rocher Yves Biolog Vegetale | COSMETIC COMPOSITION AND METHOD FOR COMBATING DEAGREABLE BODILY ODORS PRODUCED BY PERSPIRATION |
US5733535A (en) * | 1995-10-25 | 1998-03-31 | The Procter & Gamble Co. | Topical compositions containing N-acetylcysteine and odor masking materials |
US5597585A (en) * | 1995-12-26 | 1997-01-28 | Williams; Andrew H. | Vitamin/mineral composition |
DE19622708A1 (en) * | 1996-06-05 | 1997-12-11 | Tomic Dobrivoje | Aqueous compositions containing betaine |
CN1226820A (en) * | 1996-06-27 | 1999-08-25 | 普罗克特和甘保尔公司 | Cosmetic compositions |
-
1998
- 1998-07-15 DE DE19831798A patent/DE19831798A1/en not_active Withdrawn
-
1999
- 1999-07-15 AT AT99947221T patent/ATE308968T1/en not_active IP Right Cessation
- 1999-07-15 CA CA002337772A patent/CA2337772C/en not_active Expired - Fee Related
- 1999-07-15 KR KR1020017000629A patent/KR100542606B1/en not_active IP Right Cessation
- 1999-07-15 EP EP05024131A patent/EP1639991A3/en not_active Withdrawn
- 1999-07-15 HU HU0103236A patent/HUP0103236A2/en unknown
- 1999-07-15 BR BR9912821-7A patent/BR9912821A/en not_active IP Right Cessation
- 1999-07-15 EP EP99947221A patent/EP1096918B1/en not_active Expired - Lifetime
- 1999-07-15 PL PL99345689A patent/PL345689A1/en not_active Application Discontinuation
- 1999-07-15 AU AU60778/99A patent/AU761947B2/en not_active Ceased
- 1999-07-15 DK DK99947221T patent/DK1096918T3/en active
- 1999-07-15 DE DE59912774T patent/DE59912774D1/en not_active Expired - Fee Related
- 1999-07-15 DE DE19981295T patent/DE19981295D2/en not_active Expired - Lifetime
- 1999-07-15 ES ES99947221T patent/ES2252976T3/en not_active Expired - Lifetime
- 1999-07-15 JP JP2000559824A patent/JP3917370B2/en not_active Expired - Fee Related
- 1999-07-15 IL IL14088999A patent/IL140889A0/en unknown
- 1999-07-15 WO PCT/DE1999/002202 patent/WO2000003689A2/en active IP Right Grant
- 1999-07-15 CN CNB998098426A patent/CN1201723C/en not_active Expired - Fee Related
-
2001
- 2001-01-12 NO NO20010220A patent/NO20010220L/en unknown
- 2001-02-14 ZA ZA200101244A patent/ZA200101244B/en unknown
- 2001-11-09 HK HK01107891A patent/HK1037958A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20010220D0 (en) | 2001-01-12 |
CA2337772C (en) | 2009-06-09 |
HUP0103236A2 (en) | 2002-02-28 |
DK1096918T3 (en) | 2006-01-09 |
EP1639991A3 (en) | 2007-09-05 |
CN1201723C (en) | 2005-05-18 |
AU6077899A (en) | 2000-02-07 |
KR100542606B1 (en) | 2006-01-11 |
PL345689A1 (en) | 2002-01-02 |
DE59912774D1 (en) | 2005-12-15 |
CA2337772A1 (en) | 2000-01-27 |
KR20010070965A (en) | 2001-07-28 |
JP3917370B2 (en) | 2007-05-23 |
CN1313753A (en) | 2001-09-19 |
JP2002520348A (en) | 2002-07-09 |
DE19831798A1 (en) | 2000-01-27 |
ATE308968T1 (en) | 2005-11-15 |
AU761947B2 (en) | 2003-06-12 |
EP1096918A2 (en) | 2001-05-09 |
WO2000003689A2 (en) | 2000-01-27 |
EP1639991A2 (en) | 2006-03-29 |
IL140889A0 (en) | 2002-02-10 |
ZA200101244B (en) | 2003-05-14 |
ES2252976T3 (en) | 2006-05-16 |
EP1096918B1 (en) | 2005-11-09 |
NO20010220L (en) | 2001-03-13 |
WO2000003689A3 (en) | 2000-04-20 |
DE19981295D2 (en) | 2001-08-30 |
BR9912821A (en) | 2001-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL345689A1 (en) | Skin and tissue care and/or treatment agent | |
ES527150A0 (en) | A PROCEDURE FOR THE PREPARATION OF AN AQUEOUS HYDROGEN PEROXIDE DISINFECTANT SOLUTION. | |
CO5040102A1 (en) | ANTIMICROBIAL BREADS CONTAINING OF A POROUS OR ABOROUS IMPREGATED SHEET OF AN ANTIMICRO BIANA CLEANING COMPOSITION | |
ES8504449A1 (en) | Skin treatment composition. | |
NO2014010I1 (en) | Radium 223 salt such as Radium 223 dichloride | |
WO2002019966A3 (en) | Cardiac arrhythmia treatment methods | |
MX9504415A (en) | Aspartate protease substrate isoesters antiviral ethers. | |
PH31652A (en) | Dihydrolipoic acid as ophthalmological agent to suppress intolerable reactions in the aea between implants and living body tissue. | |
TR200102499T2 (en) | As a combination therapy in the treatment of neoplasia, a cyclooxygenase-2 inhibitor and a method of using one or more antineoplastic agents | |
PE32695A1 (en) | ORAL COMPOSITION | |
ECSP034678A (en) | DENTIFRICO CONTAINS ZINC OF REDUCED ASTRINGENCE | |
TR199801528T2 (en) | Dental cleaning composition containing highly soluble pyrophosphate, effective against calculus. | |
NO994431L (en) | New wording | |
MX9702456A (en) | Liquid antacid compositions containing calcium carbonate and possibly simethicone as active compounds and monobasic potassium phosphate and potassium bicarbonate as buffer. | |
PL340631A1 (en) | Azelaic acid containing composition | |
ES2125447T3 (en) | ORAL COMPOSITIONS TO TREAT PLATE AND GINGIVITIS CONTAINING A NON-CATIONIC ANTIBACTERIAL AGENT AND A BICARBONATE SALT. | |
BR9910024A (en) | Anti-cold agent | |
JPS649919A (en) | Acidic agent for permanent wave treatment | |
MXPA99011362A (en) | Use of 2-mercapto-pyridine-n-oxide. | |
ATE135915T1 (en) | AGENT FOR DECOMPOSING GALLSTONES | |
BR0115640A (en) | Composition comprising sodium, potassium, calcium and magnesium | |
TR199701617T1 (en) | An agent to be used to combat parasites in farm-produced fish. | |
GR3036481T3 (en) | Medicament containing delta-aminolevulinic acid | |
DE59803212D1 (en) | IMMOBILIZATION OF VITAMIN-A ACID BY CATIONIC POLYELECTROLYTE | |
KR930702016A (en) | Osteoporosis Drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100715 |